In the genes with diagnostic or prognostic value, loss-of-function mutations in TP53 were most prevalent (32%) detected in all three tumor types, followed by deleterious mutations in the tumor suppressor genes APC, FBXW7 and SMAD4 in CRC, and CDKN2A in MELA. The gene discussed is CDKN2A; the disease is neoplasm.